Aytu BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-17.05	-108.78	-58.29	-13.62	-27.13	-10.19	-22.51	-28.18	-7.72	-5.58
Depreciation & Amortization	8.82	10.15	9.2	5.71	2.73	2.59	4.36	0.87	0.12	0.1
Share-Based Compensation	6.05	5.25	3.57	1.08	1.03	0.6	3.01	0.9	1.02	0.5
Other Operating Activities	-2.94	64.56	19.55	-21.55	9.54	-8.94	1.3	15.74	-0.05	-0.52
Operating Cash Flow	-5.13	-28.82	-25.96	-28.37	-13.83	-15.94	-13.83	-10.66	-6.63	-5.5
Capital Expenditures	0	0	0	0	-0.06	-0.07	-0.11	-0.25	0	-0.01
Acquisitions	-0.01	-3.18	-2.82	-5.66	-1.01	-0.41	-3.42	-5.05	-1	0
Change in Investments	0	0	0	0	0	0	0	0	-0	0
Other Investing Activities	-0.11	-0.07	0.04	0.01	0	-0	-	-	-	-
Investing Cash Flow	-0.12	-3.25	-2.78	-5.66	-1.06	-0.48	-3.53	-5.3	-1	-0.01
Share Issuance / Repurchase	15.58	11.69	40.15	60.33	13.7	22.04	9.34	12.72	5	0
Debt Issued / Paid	-6.7	-10.16	-9.83	-16.25	5	0	0	4.88	7.4	4.6
Other Financing Activities	-	-0.01	-0.01	26.99	0.38	0.62	0.85	-0.93	-0.05	0.64
Financing Cash Flow	8.87	1.53	30.31	71.07	19.08	22.66	10.19	16.66	12.35	5.24
Net Cash Flow	3.63	-30.54	1.57	37.04	4.18	6.23	-7.18	0.7	4.71	-0.27
Free Cash Flow	-5.13	-28.82	-25.96	-28.37	-13.89	-16.02	-13.94	-10.91	-6.63	-5.51
Free Cash Flow Margin	-4.78%	-29.82%	-39.56%	-102.69%	-189.76%	-437.55%	-432.74%	-425.78%	-2534.25%	-9352.37%
Free Cash Flow Per Share	-1.54	-19.61	-31.01	-125.57	-356.44	-4812.17	-5983.06	-501304.03	-691640.32	-761328.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).